Search results

Narrow your search

Result types

Showing 261 - 270 of 557 for "Kim & Chang" with applied filters

News & Analysis

Disclaimer as an instrument of amendment under Section 59

23 August 2022 by LexOrbis - DPS Parmar

In normal circumstances a patentee/patent applicant resists and rather abhor curtailing or pruning of the claims of their invention. The recourse to the use instrument of disclaimer is adopted by the patent applicant/patent in extreme cases where the objection to clarify the exact scope of the invention is called into question, when they are faced with the refusal /invalidity of their patent claims.

News & Analysis

Financial Regulation Innovation: Policy Direction of FSC

16 August 2022 by Lee & Ko - South Korea

Lee & Ko’s Digital Finance Team takes a close look at the establishment of the Financial Regulation Innovation Council, the direction of the financial regulation innovation announced by the Financial Services Commission, and the points to consider in relation to future improvements to financial regulations.

News & Analysis

New Administration Displays Its Strong Will to Promote Digital Health

15 August 2022 by Lee & Ko - South Korea

Further to the 110 national initiatives for the new administration announced on May 3, 2022 (see our newsletter dated May 10, 2022), the government released a more detailed plan to promote digital health on July 27, 2022 (the Plan). The Plan was jointly prepared by the Ministry of Health and Welfare, the Ministry of Economy and Finance, the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, and the Ministry of Food and Safety.

News & Analysis

Should Hong Kong businesses be resetting their integrity agenda?

25 July 2022 by LC Lawyers

COVID-19 disrupted businesses globally and impacted the way they operate, with knock on effects on employees, counterparties and customers. Amid the turmoil, new opportunities and challenges emerged, some posing difficult ethical dilemmas affecting future viability and success of businesses. These factors created a perfect storm for misconduct. Two plus years on, we are starting to see its impact on businesses and their personnel.

News & Analysis

Introduction to a Revolutionary Reform of the Patent Remedy System in Taiwan

20 July 2022 by Tsai Lee & Chen - Taiwan

The currently effective Patent Act is the version of 2013. There were several revisions over the years, while the comprehensive structure of examination system remains largely constant. Yet the patent remedy regime implemented in the Taiwan Intellectual Property Office (“TIPO”) will inevitably embrace an enormous change followed by a draft of amendment (“Draft”) ready to enter the parliament. Inclusive of 40 articles revised, 29 added, and 7 deleted, the Draft marks a change of largest scale to the patent system since 2013.

News & Analysis

Han Kun releases its 2021 VC/PE Deal Data Analysis Report

19 July 2022 by Han Kun Law Offices - China

Biomedicine remained the No.1 investment destination, FIE structures increasingly favored by dealmakers in onshore transactions Han Kun Law Offices has released the Han Kun 2021 VC/PE Deal Data Analysis Report (English edition, the “Report”).

News & Analysis

Opposition Proceedings under the Patents (Amendment) Act 2022

11 July 2022 by Shearn Delamore & Co

In this article, Pravind Chandra looks at the new section 55A of the Patents (Amendment) Act 2022.

News & Analysis

Revised Hong Kong listing regime for overseas issuers

04 July 2022 by LC Lawyers

A revised listing regime for overseas issuers on the Stock Exchange of Hong Kong (SEHK) took effect following consultation on 1 January 2022.

News & Analysis

Cocrystallization of drugs: A new hope for medical engineering

01 July 2022 by DPS Parmar [Former Technical Member (Patents), erstwhile Intellectual Property Appellate Board Special Counsel, LexOrbis]

It is known that certain crystals can coexist as supramolecular synthons. Since the discovery of the first cocrystal of urea with NaCl in 1773 a lot has changed. In 1844, the first cocrystal of the 1:1 ratio between Benzoquinone and Hydroquinone (Quinhydrone) was obtained.

News & Analysis

ESG Series – External reviews on sustainable bonds and loans

30 June 2022 by LC Lawyers

The principles on sustainable bonds (ICMA Bond Principles) formulated by the International Capital Market Association (ICMA) are widely applied in Hong Kong listed bonds, as discussed in our previous articles. External reviews play an important part in green, social and sustainability-lined bonds/loans, and the author will summarize the common types of external reviews here.